MedPath

Vitruvias Therapeutics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

FDA:9

Drug Approvals

Memantine Hydrochloride

Approval Date
Feb 16, 2024
FDA

APur Thyroid

Approval Date
Jan 5, 2024
FDA

Cyanocobalamin

Approval Date
Dec 19, 2023
FDA

Bupropion hydrochloride (XL)

Approval Date
Apr 12, 2023
FDA

Pramipexole Dihydrochloride

Approval Date
Dec 29, 2021
FDA

Hydrocortisone Acetate

Approval Date
Jun 4, 2021
FDA

Aminocaproic Acid

Approval Date
Mar 15, 2021
FDA

Potassium Chloride

Approval Date
Feb 16, 2021
FDA

Propafenone Hydrochloride

Approval Date
Jun 27, 2019
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.